Molecular Formula | C15H18O3
|
Molar Mass | 246.3 |
Density | 1.22±0.1 g/cm3(Predicted) |
Melting Point | 100-102 °C |
Boling Point | 404.6±45.0 °C(Predicted) |
Solubility | Slightly soluble (7.9g/L) (25°C), |
Appearance | Powder |
Color | Off-White |
Storage Condition | Amber Vial, -20°C Freezer, Under inert atmosphere |
In vitro study | The antitumor activity of arglabin proceeds through its inhibition of farnesyl transferase which leads to the activation of RAS proto-oncogene, a process that is believed to play a pivotal role in 20-30% of all human tumors. It actually inhibits the incorporation of farnesyl pyrophosphate into human H-ras proteins by the enzyme farnesyl transferase (FTase). |
In vivo study | Arglabin reduces inflammation and plasma lipids, increases autophagy, and orients tissue macrophages into an anti-inflammatory phenotype in ApoE2.Ki mice fed a high-fat diet. |